Thursday, Oct 29, 2026
Focus on the big picture

Novavax Vaccine in 'Good Shape' for Approval Filing: CEO

Bloomberg, 12 May 2021
May.12 -- Novavax Inc. CEO Stan Erck says manufacturing challenges are behind the delay in the company's plan to file for authorization of its Covid-19.
Related Articles